These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 8762157)

  • 41. Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system.
    Morales M; Pickel VM
    Ann N Y Acad Sci; 2012 Feb; 1248():71-88. PubMed ID: 22171551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity.
    Navarro M; Fernández-Ruiz JJ; de Miguel R; Hernández ML; Cebeira M; Ramos JA
    Behav Brain Res; 1993 Oct; 57(1):37-46. PubMed ID: 8292253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stages of drug use acquisition among college students: implications for the prevention of drug abuse.
    Werch CE; Meers BW; Farrell J
    J Drug Educ; 1993; 23(4):375-86. PubMed ID: 8145114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nijmegen high and low responders to novelty: a new tool in the search after the neurobiology of drug abuse liability.
    Cools AR; Gingras MA
    Pharmacol Biochem Behav; 1998 May; 60(1):151-9. PubMed ID: 9610937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.
    Alcaro A; Huber R; Panksepp J
    Brain Res Rev; 2007 Dec; 56(2):283-321. PubMed ID: 17905440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mesolimbic system of the brain and its participation in the action of psychotropic substances (a review of the literature)].
    Arushanian EB
    Farmakol Toksikol; 1977; 40(5):623-30. PubMed ID: 336388
    [No Abstract]   [Full Text] [Related]  

  • 47. [Dopamine and addictive diseases].
    Ferger B; Havemann-Reinecke U; Kuschinsky K
    Med Monatsschr Pharm; 1997 Nov; 20(11):300-9. PubMed ID: 9527597
    [No Abstract]   [Full Text] [Related]  

  • 48. Rewarding, reinforcing and incentive salient events involve orexigenic hypothalamic neuropeptides regulating mesolimbic dopaminergic neurotransmission.
    Quarta D; Smolders I
    Eur J Pharm Sci; 2014 Jun; 57():2-10. PubMed ID: 24472703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sex differences in the neurobiology of drug addiction.
    Bobzean SA; DeNobrega AK; Perrotti LI
    Exp Neurol; 2014 Sep; 259():64-74. PubMed ID: 24508560
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of psychobiological states in chemical dependency: who becomes addicted?
    Neiss R
    Addiction; 1993 Jun; 88(6):745-56. PubMed ID: 8329966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Individual differences in novelty-seeking behavior but not in anxiety response to a new environment can predict nicotine consumption in adolescent C57BL/6 mice.
    Abreu-Villaça Y; Queiroz-Gomes Fdo E; Dal Monte AP; Filgueiras CC; Manhães AC
    Behav Brain Res; 2006 Feb; 167(1):175-82. PubMed ID: 16214235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug abuse: hedonic homeostatic dysregulation.
    Koob GF; Le Moal M
    Science; 1997 Oct; 278(5335):52-8. PubMed ID: 9311926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
    Jentsch JD; Roth RH; Taylor JR
    Prog Brain Res; 2000; 126():433-53. PubMed ID: 11105661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The COMT Val158Met polymorphism is associated with novelty seeking in Czech methamphetamine abusers: preliminary results.
    Hosák L; Libiger J; Cizek J; Beránek M; Cermáková E
    Neuro Endocrinol Lett; 2006 Dec; 27(6):799-802. PubMed ID: 17187009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The SEEKING mind: primal neuro-affective substrates for appetitive incentive states and their pathological dynamics in addictions and depression.
    Alcaro A; Panksepp J
    Neurosci Biobehav Rev; 2011 Oct; 35(9):1805-20. PubMed ID: 21396397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neurobiology of addiction to drugs of abuse].
    Gil-Verona JA; Pastor JF; de Paz F; Barbosa M; Macias-Fernández JA; Maniega MA; Rami-González L; Cañizares-Alejos S
    Rev Neurol; 2003 Feb 15-28; 36(4):361-5. PubMed ID: 12599136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influences of social reward experience on behavioral responses to drugs of abuse: Review of shared and divergent neural plasticity mechanisms for sexual reward and drugs of abuse.
    Beloate LN; Coolen LM
    Neurosci Biobehav Rev; 2017 Dec; 83():356-372. PubMed ID: 29108963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug addiction. Part II. Neurobiology of addiction.
    Vetulani J
    Pol J Pharmacol; 2001; 53(4):303-17. PubMed ID: 11990077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Innately low D2 receptor availability is associated with high novelty-seeking and enhanced behavioural sensitization to amphetamine.
    Tournier BB; Steimer T; Millet P; Moulin-Sallanon M; Vallet P; Ibañez V; Ginovart N
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1819-34. PubMed ID: 23574629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.